Lucy J Holt

Title: Innovations of Lucy J Holt

Introduction

Lucy J Holt is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of novel drug compositions and therapeutic agents. With a total of 2 patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

One of her latest patents is titled "Ligand." This invention provides a dual-specific ligand comprising a first immunoglobulin variable domain with a first binding specificity and a complementary or non-complementary immunoglobulin variable domain with a second binding specificity. Another notable patent is for "Bispecific fusion antibodies with enhanced serum half-life." This patent describes drug compositions, fusions, and conjugates that contain a therapeutic or diagnostic agent fused or conjugated to an antigen-binding fragment of an antibody that binds serum albumin. These drug compositions have a longer in vivo half-life compared to unconjugated or unfused therapeutic or diagnostic agents.

Career Highlights

Lucy J Holt is currently associated with Domantis Limited, where she continues to innovate and develop new therapeutic solutions. Her work is characterized by a strong focus on enhancing the efficacy and longevity of drug treatments.

Collaborations

Some of her notable coworkers include Ian M Tomlinson and Laurent S Jespers, who contribute to her research and development efforts.

Conclusion

Lucy J Holt's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative approaches to drug development are paving the way for advancements in medical treatments.